A Scoring System to Determine Patients' Risk of Colectomy Within 1 y After Hospital Admission for Acute Severe Ulcerative Colitis.

[1]  K. Ohtsuka,et al.  Predictors of mucosal healing during induction therapy in patients with acute moderate‐to‐severe ulcerative colitis , 2019, Journal of gastroenterology and hepatology.

[2]  L. Simms,et al.  The effect of pre-admission immunosuppression on colectomy rates in acute severe ulcerative colitis , 2018, Therapeutic advances in gastroenterology.

[3]  G. Radford-Smith,et al.  Predicting response after infliximab salvage in acute severe ulcerative colitis , 2018, Journal of gastroenterology and hepatology.

[4]  S. Travis,et al.  Predictors of long‐term outcomes in patients with acute severe colitis: A northern Indian cohort study , 2018, Journal of gastroenterology and hepatology.

[5]  Chenyan Zhao,et al.  Fecal calprotectin as an alternative to ulcerative colitis endoscopic index of severity to predict the response to corticosteroids of acute severe ulcerative colitis: A prospective observational study. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  J. Efron,et al.  Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes , 2017, Journal of Gastrointestinal Surgery.

[7]  G. Watermeyer,et al.  Predictors of emergency colectomy in patients admitted with acute severe ulcerative colitis. , 2017, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

[8]  H. Mulcahy,et al.  CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis , 2017, Journal of clinical gastroenterology.

[9]  Chao Ding,et al.  Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis , 2017, Gastroenterology report.

[10]  S. Khanna,et al.  Systematic review with meta‐analysis: the impact of Clostridium difficile infection on the short‐ and long‐term risks of colectomy in inflammatory bowel disease , 2017, Alimentary pharmacology & therapeutics.

[11]  V. Annese,et al.  Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  J. Mansfield,et al.  Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial , 2016, The lancet. Gastroenterology & hepatology.

[13]  I. Arnott,et al.  Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data , 2016, Alimentary pharmacology & therapeutics.

[14]  Judy H. Cho,et al.  Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis , 2016, Gut.

[15]  G. Leontiadis,et al.  Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids , 2016, The American Journal of Gastroenterology.

[16]  P. Sahni,et al.  Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome , 2015, International Journal of Colorectal Disease.

[17]  J. Satsangi,et al.  Predicting outcomes in acute severe ulcerative colitis , 2015, Expert review of gastroenterology & hepatology.

[18]  H. Sokol,et al.  Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  A. Gasbarrini,et al.  Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy. , 2014, Journal of Crohn's & colitis.

[20]  G. Collins,et al.  Predicting the Individual Risk of Acute Severe Colitis at Diagnosis , 2014, Journal of Crohn's & colitis.

[21]  J. Rhodes,et al.  Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit , 2013, Alimentary pharmacology & therapeutics.

[22]  S. Vermeire,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.

[23]  S. Vermeire,et al.  Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management , 2012 .

[24]  J. Gisbert,et al.  Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial , 2012, The Lancet.

[25]  G. Kaplan,et al.  Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. , 2008, Gastroenterology.

[26]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[27]  A. Gasbarrini,et al.  Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up , 2007, Alimentary pharmacology & therapeutics.

[28]  R. Prescott,et al.  Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery , 2004, Alimentary pharmacology & therapeutics.

[29]  R. Löfberg,et al.  Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis , 1998, European journal of gastroenterology & hepatology.

[30]  D. Jewell,et al.  Predicting outcome in severe ulcerative colitis. , 1996, Gut.

[31]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[32]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[33]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .

[34]  T. Molnár,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. , 2017, Journal of Crohn's & colitis.

[35]  A. Griffiths,et al.  Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.